Work

Low-cost urine tenofovir assay to triage dolutegravir resistance testing

Year: 2024

Type: article

Source: The Lancet HIV

DOI: 10.1016/s2352-3018(24)00060-2

Authors: Tyler Martinson, Jacinta Nwogu-Attah, Matthew Spinelli, Monica Gandhi

Institutions: Kaiser Permanente, University of California, San Francisco, Kaiser Permanente San Francisco Medical Center, Lead City University

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Abbott Laboratories, Gilead Sciences, National Institutes of Health, National Institute of Allergy and Infectious Diseases

Awards: G3726674119, Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING-PUMA)

OpenAlex ID: W4392564462

FWCI: 2.522

Cites: 4

Cited by: 8

Related to: 10